Potential of mezlocillin as empiric single-agent therapy in febrile granulocytopenic cancer patients.
Saved in:
| Title: | Potential of mezlocillin as empiric single-agent therapy in febrile granulocytopenic cancer patients. |
|---|---|
| Authors: | Wade JC, Schimpff SC, Newman KA, Fortner CL, Moody MR, Young VM, Wiernik PH |
| Source: | Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 1980 Aug; Vol. 18 (2), pp. 299-306. |
| Publication Type: | Clinical Trial; Controlled Clinical Trial; Journal Article |
| Journal Info: | Publisher: American Society for Microbiology Country of Publication: United States NLM ID: 0315061 Publication Model: Print Cited Medium: Print ISSN: 0066-4804 (Print) Linking ISSN: 00664804 NLM ISO Abbreviation: Antimicrob Agents Chemother Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
